somatic symptom disorder. Somatization disorder
Conditions
Interventions
Intervention 1: Control group: The content of the control group program (1) is routine education for people with somatic symptom disorders. Currently, in clinics, it is only a referral to a psychiatri
however, they are informed that more specialized educational files will be sent to them at the end of the study. This program does not include specialized support
guidance is provided solely on how to use the files. Intervention 3: Intervention group: The
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age 18 years or older Diagnosis of Somatic Symptom Disorder confirmed by a psychiatrist (specialist) with a fellowship in psychosomatic medicine, using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic interview conducted by the researcher with the patient, and a score higher than 130 on the Lacourt Psychosomatic Symptoms Questionnaire. Sufficient literacy (ability to read and write) Willingness to participate in the study Ability to speak Persian (Farsi) Not having participated in the qualitative phase of the intervention
Exclusion criteria
Exclusion criteria: Presence of psychotic psychiatric disorders (such as schizophrenia and bipolar disorder) Having a diagnosis of substance abuse disorder Attending psychotherapy sessions under the supervision of a psychologist or psychiatrist in the past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of psychological flexibility. Timepoint: Before intervention After intervention 3 months later. Method of measurement: The Acceptance and Action Questionnaire-II (AAQ-II).;Quality of Life. Timepoint: Before intervention After intervention 3 months later. Method of measurement: The World Health Organization quality of Life (WHOQOL-BREF) questionnaire.;Emotion Regulation. Timepoint: Before intervention After intervention 3 months later. Method of measurement: Emotion Regulation Questionnaire.;Sleep quality. Timepoint: Before intervention After intervention 3 months later. Method of measurement: Sleep quality Q.;Scale of Pain. Timepoint: Before intervention After intervention 3 months later. Method of measurement: Analouge visual scale (VAS) in pain severity.;Lacourt psychosomatic symptoms. Timepoint: Analouge visual scale (VAS) in pain severity. Method of measurement: Lacourt psychosomatic symptoms questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Mirshah
Shiraz University of Medical Sciences
Outcome results
None listed